Ignite Creation Date:
2024-05-05 @ 5:04 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00372060
Status:
COMPLETED
Last Update Posted:
2017-05-12
First Post:
2006-09-05
Brief Title:
MK0431 Sitagliptin Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus 0431-055COMPLETED
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-08-21
Start Date Type:
ACTUAL
Primary Completion Date:
2008-02-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-02-05
Completion Date Type:
ACTUAL
First Submit Date:
2006-09-05
First Submit QC Date:
September 5 2006
Study First Post Date:
2006-09-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2009-03-31
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-04-06
Last Update Post Date:
2017-05-12
Last Update Post Date Type:
ACTUAL